Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Alligator Bioscience AB ( (SE:ATORX) ) is now available.
Alligator Bioscience AB has increased its total number of outstanding shares and votes to 534,516,986 ordinary shares as of 30 January 2026, following a rights issue of units approved in late 2025 and a subsequent directed issue of units to guarantors. The expanded share base reflects the company’s ongoing capital-raising efforts to support its strategic and operational needs, potentially affecting existing shareholders through dilution while strengthening Alligator Bioscience’s financial position and flexibility within the competitive biotech sector.
The most recent analyst rating on (SE:ATORX) stock is a Sell with a SEK0.18 price target. To see the full list of analyst forecasts on Alligator Bioscience AB stock, see the SE:ATORX Stock Forecast page.
More about Alligator Bioscience AB
Alligator Bioscience AB is a Swedish biotechnology company based in Lund, focused on developing innovative immuno-oncology therapies, with its operations centered around advancing biologic drug candidates for cancer treatment.
Average Trading Volume: 5,024,688
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK97.23M
For an in-depth examination of ATORX stock, go to TipRanks’ Overview page.